$159.4M
sold in all offerings
OnKure Therapeutics, Inc. is a corporation based in Boulder, CO in the Pharmaceuticals industry group. From January 8, 2018 to October 21, 2024 it filed 4 private fundraising filings for 4 offerings and reported $159 million sold in all. It is a listed company (OKUR).
Updated November 11, 2026 · newest filing Oct 21, 2024
Amount sold
$159.4M
All offerings, newest filing of each
Offered
$236.8M
Total amount sought
Offerings
4
4 filings with amendments
Newest offering
$65.0M
Sold, first filed Oct 21, 2024
Investors
20
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- Boulder, CO
- Industry group
- Pharmaceuticals
- Listed
- OKUR
- First filing
- January 8, 2018
- Newest filing
- October 21, 2024
- Exemptions
- 506(b)
- Other names
- Reneo Pharmaceuticals, Inc.
Amount sold by year
Each offering in the year of its first filing, at its newest amount sold
Amount sold by year
Offerings
4 offerings, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Oct 21, 2024 | $65.0M | $65.0M | 20 | - | 506(b) | Equity |
| Dec 21, 2020 | $47.4M | $94.8M | 15 | - | 506(b) | Equity |
| May 14, 2019 | $25.0M | $25.0M | 9 | - | 506(b) | Equity |
| Jan 8, 2018 | $22.0M | $52.0M | 16 | - | 506(b) | Equity |
Filing history
4 filings, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Oct 21, 2024 | New offering | $65.0M | $65.0M | 20 |
| Dec 21, 2020 | New offering | $47.4M | $94.8M | 15 |
| May 14, 2019 | New offering | $25.0M | $25.0M | 9 |
| Jan 8, 2018 | New offering | $22.0M | $52.0M | 16 |
Related pages
Questions and answers
How much has OnKure Therapeutics, Inc. raised in private offerings?
$159 million sold in 4 private offerings reported from Jan 8, 2018 to Oct 21, 2024, counting each offering once at its newest filing.
When did OnKure Therapeutics, Inc. last file about a private offering?
October 21, 2024. Its newest offering reported $65 million sold of $65 million offered to 20 investors.
Which exemption does OnKure Therapeutics, Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is OnKure Therapeutics, Inc. a listed company?
Yes, it is listed as OKUR.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.